title: Benefits, efficacy, cost-effectiveness and infectious complications in transplant patients desensitized with intravenous immunoglobulin and anti-CD20 therapy.
authors.affiliation: Kidney Transplant, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
authors.forename: A A
authors.initials: AA
authors.lastname: Vo
authors.forename: S C
authors.initials: SC
authors.lastname: Jordan
mesh_terms: D018951:Antigens, CD20 / Q000008:administration & dosage* / Q000276:immunology*; D003362:Cost-Benefit Analysis / Q000379:methods; D003888:Desensitization, Immunologic / Q000379:methods; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage* / Q000276:immunology*; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000379:methods; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D019737:Transplants / Q000276:immunology*
chemical_list: D018951:Antigens, CD20; D016756:Immunoglobulins, Intravenous